A new cancer vaccine, aimed at preventing the disease from developing, is being developed by pharma giant GSK and the University of Oxford. The vaccine is intended to target cells at the pre ...

Sir Chris Hoy's efforts to increase prostate cancer awareness have helped drive up referrals to specialists, an NHS trust said. Between 100 and 150 more people a week in Oxfordshire are being referred ...

"Working together, we will greatly accelerate translational research that could lead to the development of vaccines to prevent cancer in the future." GSK and Oxford University are already ...

Immunotherapy is a fast-growing approach for cancer treatment ... than killer T cells. Enter Oxford Vacmedix and its ROPs. Back in 2000, while at Harvard University, the company’s founder ...

The test, by University College London (UCL) spinout company Sola Diagnostics, has been approved for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) for women over the ...